Related Experiment Video
Updated: Jun 27, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Gastrointestinal eosinophil-mediated disorders and their treatment
1Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. amal.assa'ad@cchmc.org
Abstract:
Eosinophilic esophagitis has become a diagnosis familiar to allergists and immunologists who treat pediatric patients presenting with complaints of recurrent vomiting, feeding difficulty, abdominal pain, dysphagia, and food impaction. Over the past 3 years, published research has addressed several clinically important issues, including incidence among special patient populations, adult patients and familial cases, diagnostic features, natural history and complications, therapies with topical steroids, and pathogenesis with distinct genetic markers of the disorder.
Related Concept Videos
Other Disorders of Digestive System
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Gastrointestinal Motility Disorders
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
